% | $
Quotes you view appear here for quick access.

Affymetrix Inc. Message Board

  • isce_ille_iste isce_ille_iste Oct 8, 2012 9:34 AM Flag

    Not so good news . . . AFFX warns . . .

    Affymetrix expects 3Q revenue below Street's view
    Affymetrix expects 3rd-quarter revenue below Wall Street's expectations

    SANTA CLARA, Calif. (AP) -- Life science instrument company Affymetrix anticipates that its third-quarter revenue will come in below Wall Street's expectations, as its results were hurt by tighter academic funding conditions globally.
    Affymetrix Inc. said Monday that it anticipates quarterly revenue of about $80 million, with approximately $18 million coming from its eBioscience business.
    Analysts polled by FactSet expect revenue of $84.6 million.
    The company said that the tighter funding conditions mostly hurt its gene expression and eBioscience divisions.
    President and CEO Frank Witney said in statement that Affymetrix now expects its 2012 revenue will be flat to slightly down from the prior year due to concerns about the tighter funding conditions and a weaker euro. The Santa Clara, Calif.-based company had 2011 revenue of $267.5 million.
    Affymetrix will report its third-quarter financial results on Oct. 31.
    Affymetrix shares finished at $4.31 on Friday. Its shares are up 22 percent from a low of $3.52 on Aug. 23. They traded as high #$%$95 last October.

14.010.00(0.00%)Mar 31 4:00 PMEDT